The Doctor's Dose

Merck Keytruda Medicare Delay: What It Means for Day Traders The recent tweak to Medicare’s drug price negotiation program has given Merck (MRK) a brief lifeline. While long-term investors are debating whether the change truly softens the looming Keytruda patent...

A Tweak to Medicare is Good for Merck. But Can It Revive the Stock? Merck & Co. has found a small reprieve in Washington, but investors remain skeptical that it will meaningfully alter the company’s trajectory. A new tweak to Medicare’s drug price negotiation...

September Fed Rate Cut: Why Day Traders Should Prepare for a Hawkish Surprise Fed expectations vs. market reality The S&P 500, currently hovering above 6400, has rallied on expectations of a September Fed rate cut. Fed funds futures are pricing an 85% chance of a...

The Manz Trader Readiness Inventory: Measuring Psychological Fitness for Day Trading Success in day trading is about much more than mastering technical setups or memorizing chart patterns. While strategy and execution are essential, they’re only part of the equation....

Intel Government Stake Talks and Day Trading Implications The Trump administration is reportedly considering a 10% equity stake in Intel (INTC), which would convert billions in CHIPS Act funding into ownership. The proposal underscores Washington’s deepening...

Retail Earnings, Tariffs, and Day Trading: Where the Real Risk Lies Why this week matters Headline numbers may look fine; the risk is guidance as retailers speak to the back half (B2S and holiday). Tariff pass-through is the swing factor: modest so far, but price...

Novo Nordisk Wegovy MASH approval: Why NVO is jumping—and how day traders can trade it Quick take Novo Nordisk shares pop after the FDA grants accelerated approval for Wegovy to treat MASH (metabolic dysfunction-associated steatohepatitis) with liver fibrosis in...

DeepSeek’s AI Model Delay and the Impact on Intraday Trading Opportunities China’s AI Ambitions Face Technical Headwinds The delay in the DeepSeek AI model underscores a significant challenge in Beijing’s push to reduce reliance on U.S. technology. The Chinese AI...

Weight-Loss Drug Stocks and Day Trading Opportunities Pharma’s Former Darling Turns Volatile The meteoric rise of weight-loss drug stocks such as Novo Nordisk and Eli Lilly was once seen as a safe haven in the pharmaceutical sector. Fueled by the popularity of GLP-1...

Zelensky–Trump Meeting Market Impact: What Traders Should Expect As President Volodymyr Zelensky returns to Washington with a cohort of European leaders, the Zelensky–Trump meeting market impact will hinge on three things: the shape of potential security guarantees,...

Big Tech AI Talent War: How Reverse Acquihires Could Reshape Silicon Valley The Big Tech AI talent war is pushing Microsoft, Meta, Google and others to pursue a new playbook—poach founders and core researchers, license the IP, and leave the startup shell behind. It’s...

Disney and Marvel Leaving Georgia: Intraday Stock Action & What It Means for Cleveland What Happened (and Why It Matters) Reports indicate Disney’s Marvel is shifting most big-budget productions away from Georgia and toward the United Kingdom, citing a better...

Trump’s Emerging Market Behavior: Is the US Beginning to Look Like Argentina? For decades, the United States has been the world’s benchmark for financial stability, transparency, and institutional independence. Yet in President Donald Trump’s second term, analysts and...

Housing Market Correction Indicators: 3 Key Trends to Watch Despite appearing stagnant on the surface, the U.S. housing market is showing early signs of a potential shift—and possibly a correction. Economists are closely monitoring several key indicators to assess...

Uber’s Autonomous Ambitions Spark Tesla Volatility: What Traders Need to Watch Shares of Uber Technologies (UBER) climbed in early trading Wednesday after the company posted strong second-quarter earnings, beat across key metrics, and unveiled a $20 billion share...